In spite of the puzzling mechanism, this study proves a direct link between lncRNA and BC resistance to therapies targeting PI3K/AKT/mTOR pathways, again suggesting that lncRNAs are promising therapeutic targets to overcome BC resistance. This evidence concerns the gene AKT1 and breast cancer.